LianBio Increase (Decrease) in Other Receivables
LianBio (LIANY) reported Increase (Decrease) in Other Receivables of -$860.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2023-11-13
- LianBio increase (decrease) in other receivables for the quarter ending 2023-09-30 was -$115.00K.
- LianBio increase (decrease) in other receivables for the quarter ending 2023-06-30 was $12.00K, a 99.06% decline year-over-year.
- LianBio increase (decrease) in other receivables for the quarter ending 2023-03-31 was -$757.00K.
- LianBio increase (decrease) in other receivables for the quarter ending 2022-12-31 was $156.00K.
- LianBio increase (decrease) in other receivables for fiscal 2022 was $1.40M.
- LianBio increase (decrease) in other receivables for fiscal 2021 was -$14.22M, a 171.08% decline from fiscal 2020.
- LianBio increase (decrease) in other receivables for fiscal 2020 was $20.00M.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$103.00K derived: sum of 2 quarters · filed 2023-11-13 | -$860.00K 10-Q · filed 2023-11-13 | -$704.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$745.00K 10-Q · filed 2023-08-14 | -$589.00K derived: sum of 3 quarters · filed 2023-08-14 | -$626.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$757.00K 10-Q · filed 2023-05-11 | -$601.00K derived: sum of 2 quarters · filed 2023-05-11 | -$638.00K derived: sum of 3 quarters · filed 2023-11-13 | $643.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $119.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.40M derived: sum of 3 quarters · filed 2023-11-13 | $1.40M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.24M derived: sum of 2 quarters · filed 2023-11-13 | $1.24M 10-Q · filed 2023-11-13 | $1.24M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.28M 10-Q · filed 2023-08-14 | $1.28M derived: sum of 3 quarters · filed 2023-08-14 | $7.07M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $5.78M derived: sum of 3 quarters · filed 2023-05-11 | $5.78M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $5.78M derived: sum of 2 quarters · filed 2023-03-28 | $5.78M derived: sum of 3 quarters · filed 2023-03-28 | -$14.22M 10-K · filed 2023-03-28 |
| 2021-09-30 | $5.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $5.78M derived: sum of 2 quarters · filed 2022-11-10 | -$14.22M 10-Q · filed 2022-11-10 | $5.78M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$20.00M 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$20.00M 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $20.00M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $20.00M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $0.00 10-Q/A · filed 2022-01-10 |